Schering GMPs: Over 25% Of Consent Decree Steps Complete, Company Says
Executive Summary
Schering-Plough is over a quarter of the way through fulfilling its requirements under a 2002 consent decree
You may also be interested in...
Schering adds compliance exec
Former Lilly Chief Compliance Officer Lori Queisser takes over as Schering-Plough's Senior-VP Global Compliance & Business Practices starting Feb. 20. Schering's current compliance chief Brent Saunders is being promoted to Senior VP & President-Consumer Health Care effective June 1, where he will lead Schering's U.S. and Canadian consumer unit. Saunders joined the firm in November 2003 to serve in the then newly-created compliance position (1"The Pink Sheet" Oct. 13, 2003, p. 17). Schering is nearing completion of a compliance-related consent decree from 2002. Both Saunders and Queisser will report to CEO Fred Hassan...
Schering adds compliance exec
Former Lilly Chief Compliance Officer Lori Queisser takes over as Schering-Plough's Senior-VP Global Compliance & Business Practices starting Feb. 20. Schering's current compliance chief Brent Saunders is being promoted to Senior VP & President-Consumer Health Care effective June 1, where he will lead Schering's U.S. and Canadian consumer unit. Saunders joined the firm in November 2003 to serve in the then newly-created compliance position (1"The Pink Sheet" Oct. 13, 2003, p. 17). Schering is nearing completion of a compliance-related consent decree from 2002. Both Saunders and Queisser will report to CEO Fred Hassan...
Schering GMP Work Plan Is One-Third Complete; Toughest Battles Lie Ahead
The remaining two-thirds of Schering-Plough's GMP work plan contain the most challenging requirements under the company's 2002 manufacturing consent decree, CEO Fred Hassan told analysts Nov. 18